Through the Allergist Lens: Achieving Optimal Outcomes in Patients with Mild to Moderate Atopic Dermatitis

Sunday, February 24, 2019
6:30 PM – 8:30 PM
Golden Gate A Ballroom
San Francisco Marriott Marquis
780 Mission Street
San Francisco, CA 94103

 

AGENDA

6:30 PM – 7:00 PM       Registration/Dinner Served
7:00 PM – 8:15 PM       Practitioner’s Edge SM  Scientific Session
8:15 PM – 8:30 PM       Question & Answer Session/Closing Remarks

PRACTITIONER’S EDGESM PANEL
Faculty Chair

Mark Boguniewicz, MD
Professor, Division of Allergy-Immunology
Department of Pediatrics
National Jewish Health
University of Colorado School of Medicine
Denver, Colorado

Faculty

Peck Ong, MD
Associate Professor of Clinical Pediatrics
Keck School of Medicine
University of Southern California
Los Angeles, California

Myron J. Zitt, MD
Associate Professor of Clinical Medicine
Department of Medicine
State University of New York
Stony Brook, New York
Director
Adult Allergy Clinic
Nassau University Medical Center
East Meadow, New York

PROGRAM OVERVIEW

Numerous factors contribute to suboptimal outcomes in the treatment of patients with atopic dermatitis (AD), including uncertainty among healthcare providers about optimal strategies for diagnosis and assessment of severity, and management approaches that are inconsistent with current evidence-based recommendations and guidelines. The program is designed to address these issues by educating clinicians about overall strategies that have been demonstrated to improve outcomes in patients with AD, particularly those with mild to moderate disease. This activity will include information on how to make safe and efficacious choices among established and emerging pharmacotherapies based on up-to-date clinical data. Additionally, this educational activity will provide clinicians with guidance on how to facilitate treatment adherence and improve outcomes through improved communication strategies.

PROGRAM FORMAT

Practitioner’s EdgeSM Workshops are innovative, interactive meetings that provide attendees with cutting edge medical education in a peer-to-peer discussion setting. Practitioner’s EdgeSM provides the practicing healthcare provider with tools and education that may be utilized immediately in daily practice.

In this Practitioner’s EdgeSM program, case studies will be utilized to illustrate issues related to patients with AD. Audience participation will be invited via interactive questions interspersed throughout the program. The results of the interactive questions will serve as a catalyst for faculty discussion and best-practice reinforcement.

TARGET AUDIENCE

This educational initiative has been designed for allergists, immunologists, nurse practitioners, physician assistants, and any healthcare professionals involved in the management and treatment of patients with AD.

LEARNING OBJECTIVES

Upon completion of this educational activity, participants should be able to:

  • •  Recognize the most recent clinical practice guidelines and recommendations for AD
  • •  Evaluate strategies to facilitate accurate diagnosis and severity assessment in patients with AD
  • •  Translate the safety and efficacy data of established and emerging therapies into patient-focused treatment plans for patients with mild-to-moderate AD
  • •  Analyze the benefit of AD action plans, improved communication, and SDM to improve treatment adherence in patients with AD
REGISTRATION

There is no registration fee for attending this symposium; however, seating is limited. To register, click the button at the top right of this page or call Integrity Continuing Education, Inc. at 1-855-835-4004.  Preregistration does not guarantee seating. We recommend arriving at the meeting location early.

DISCLOSURE OF CONFLICTS OF INTEREST

Integrity Continuing Education, Inc. requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Integrity Continuing Education, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

A detailed disclosure for all persons in control of content, including faculty presenters, will be provided at the live event.

DISCLAIMER

The information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient’s medical condition.

This program is not sponsored or programmed by the AAAAI.

Provided by Integrity Continuing Education, Inc.

Supported by an educational grant from Pfizer.

 

Agenda

6:30 PM – 7:00 PM Registration
7:00 PM – 8:15 PM
Welcome, Introductions, and Overview of AD
Diagnostic Strategies in AD
Pathophysiology of AD
Clinical Case Discussion
Approach to Treatment of AD
Improving Patient Satisfaction with Treatment
8:15 PM – 8:30 PM Question & Answer Session/Closing Remarks